Disease burden of systemic light-chain amyloidosis: a systematic literature reviewHuamao Mark Lin, Parameswaran Hari, Richard Labotka et al.|Current Medical Research and Opinion|2017Cited by 32
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trialMeletios Α. Dimopoulos, Shaji Kumar, Fredrik Schjesvold et al.|Blood Cancer Journal|2022Cited by 21